Viewing Study NCT05805956


Ignite Creation Date: 2025-12-24 @ 11:35 PM
Ignite Modification Date: 2026-06-25 @ 1:07 AM
Study NCT ID: NCT05805956
Status: UNKNOWN
Last Update Posted: 2023-04-10
First Post: 2023-03-23
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: IMM2902 in Patients With Advanced Solid Tumors Expressing HER2
Sponsor: ImmuneOnco Biopharmaceuticals (Shanghai) Inc.
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Advanced Solid Tumor View
None Advanced Lung Cancer View
None Advanced Gastric Carcinoma View
None Advanced Cholangiocarcinoma View
Keywords: